BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yilmaz Y. Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome? World J Hepatol 2012; 4(12): 332-334 [PMID: 23355910 DOI: 10.4254/wjh.v4.i12.332]
URL: https://www.wjgnet.com/1948-5182/full/v4/i12/332.htm
Number Citing Articles
1
E. Sabath, A. Báez‐Ruiz, R. M. Buijs. Non‐alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronizationObesity Reviews 2015; 16(10): 871 doi: 10.1111/obr.12308
2
R. J. Wong, B. Liu, T. Bhuket. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross‐sectional analysis of 2011‐2014 National Health and Nutrition Examination SurveyAlimentary Pharmacology & Therapeutics 2017; 46(10): 974 doi: 10.1111/apt.14327
3
Mehmet Celikbilek, Mevlut Baskol, Serpil Taheri, Kemal Deniz, Serkan Dogan, Gokmen Zararsiz, Sebnem Gursoy, Kadri Guven, Omer Ozbakır, Munis Dundar, Mehmet Yucesoy. Circulating microRNAs in patients with non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(8): 613-620 doi: 10.4254/wjh.v6.i8.613
4
Vanda Marques, Marta B. Afonso, Nina Bierig, Filipa Duarte-Ramos, Álvaro Santos-Laso, Raul Jimenez-Agüero, Emma Eizaguirre, Luis Bujanda, Maria J. Pareja, Rita Luís, Adília Costa, Mariana V. Machado, Cristina Alonso, Enara Arretxe, José M. Alustiza, Marcin Krawczyk, Frank Lammert, Dina G. Tiniakos, Bertram Flehmig, Helena Cortez-Pinto, Jesus M. Banales, Rui E. Castro, Andrea Normann, Cecília M. P. Rodrigues. Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLDFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.683250
5
Asuman Celikbilek, Mehmet Celikbilek, Aylin Okur, Serkan Dogan, Elif Borekci, Mustafa Kozan, Sebnem Gursoy. Non-alcoholic fatty liver disease in patients with migraineNeurological Sciences 2014; 35(10): 1573 doi: 10.1007/s10072-014-1798-1
6
Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse modelJournal of Functional Foods 2016; 20: 516 doi: 10.1016/j.jff.2015.11.029
7
K. Sarat Chandra, Manish Bansal, Tiny Nair, S.S. Iyengar, Rajeev Gupta, Subhash C. Manchanda, P.P. Mohanan, V. Dayasagar Rao, C.N. Manjunath, J.P.S. Sawhney, Nakul Sinha, A.K. Pancholia, Sundeep Mishra, Ravi R. Kasliwal, Saumitra Kumar, Unni Krishnan, Sanjay Kalra, Anoop Misra, Usha Shrivastava, Seema Gulati. Consensus statement on management of dyslipidemia in Indian subjectsIndian Heart Journal 2014; 66: S1 doi: 10.1016/j.ihj.2014.12.001
8
Eda Kaya, Yusuf Yilmaz. Obesity and Diabetes2020; : 321 doi: 10.1007/978-3-030-53370-0_24
9
Luca Miele, Giovanni Gasbarrini, Valentina Giorgio, Antonio Gasbarrini, Antonio Grieco. Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndromeInternal and Emergency Medicine 2016; 11(1): 3 doi: 10.1007/s11739-015-1346-x
10
Yao-Bin Nong, Hong-Na Huang, Jing-Jing Huang, Yuan-Qin Du, Wen-Xuan Song, De-Wen Mao, Yue-Xue Zhong, Rong-Huo Zhu, Xi-Yu Xiao, Rui-Xi Zhong. Rare leptin in non-alcoholic fatty liver cirrhosis: A case reportWorld Journal of Clinical Cases 2022; 10(28): 10293-10300 doi: 10.12998/wjcc.v10.i28.10293
11
Young Eun Chon, Kyu Sik Jung, Kwang Joon Kim, Dong Jin Joo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim. Normal Controlled Attenuation Parameter Values: A Prospective Study of Healthy Subjects Undergoing Health Checkups and Liver Donors in KoreaDigestive Diseases and Sciences 2015; 60(1): 234 doi: 10.1007/s10620-014-3293-1
12
Cidália D. Pereira, Emanuel Passos, Milton Severo, Isabel Vitó, Xiaogang Wen, Fátima Carneiro, Pedro Gomes, Rosário Monteiro, Maria J. Martins. Ingestion of a natural mineral-rich water in an animal model of metabolic syndrome: effects in insulin signalling and endoplasmic reticulum stressHormone Molecular Biology and Clinical Investigation 2016; 26(2): 135 doi: 10.1515/hmbci-2015-0033
13
Yusuf Yilmaz. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease2016; : 44 doi: 10.1002/9781118924938.ch6
14
Amandeep Singh, Amaninder S. Dhaliwal, Shailainder Singh, Atul Kumar, Rocio Lopez, Mohit Gupta, Mazen Noureddin, William Carey, Arthur McCullough, Naim Alkhouri. Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US CohortDigestive Diseases and Sciences 2020; 65(4): 978 doi: 10.1007/s10620-019-05700-9
15
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, Javier Crespo, José Luis Calleja, Carmelo García-Monzón, Judith Gómez-Camarero, Joan Caballería, Oreste Lo Iacono, Luis Ibañez, Javier García-Samaniego, Agustín Albillos, Rubén Francés, Conrado Fernández-Rodríguez, Moisés Diago, Germán Soriano, Raúl J. Andrade, Raquel Latorre, Francisco Jorquera, Rosa María Morillas, Desamparados Escudero, Pamela Estévez, Manuel Hernández Guerra, Salvador Augustín, Jesús M. Banales, Patricia Aspichueta, Salvador Benlloch, José Miguel Rosales, Javier Salmerón, Juan Turnes, Manuel Romero Gómez. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASHJournal of Hepatology 2020; 73(1): 17 doi: 10.1016/j.jhep.2020.02.028
16
Kenneth N Litwak, Susan Levin. Effects of excess dietary fructose on liver pathology study have significant methodologic limitationsThe American Journal of Clinical Nutrition 2014; 99(1): 209 doi: 10.3945/ajcn.113.074625